Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-25-018231
Filing Date
2025-04-17
Accepted
2025-04-17 16:20:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A esperion-definitiveproxyxp.htm DEFA14A 12163
2 proxynoticecard-back.jpg GRAPHIC 92669
3 proxynoticecard-front.jpg GRAPHIC 126362
  Complete submission text file 0001628280-25-018231.txt   315122
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35986 | Film No.: 25847602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)